Contact: John Sterling, 914-740-2196, email@example.com
GEN Presents Contract Services Summit and Drug Discovery Theater at BIO
New Rochelle, NY, June 20, 2011-Genetic Engineering & Biotechnology News (GEN) will host a Contract Services Summit and Drug Discovery Theater at the Annual BIO International conference in Washington, DC, later this month.
Rising costs, new regulatory requirements, growing global competition, and the quickening pace of technology innovation are increasing the pressure on biotech companies to develop more focused product-development strategies-all the way from drug discovery through commercial manufacturing. Join us to listen to and discuss current trends and business challenges for drug discovery, clinical trials, and contract research and contract manufacturing operations.
The GEN Contract Services Summit will take place on Tuesday, June 28, from 2:15 pm until 5:00 pm at the GEN Theater (Booth #4243) on the BIO Exhibition Floor. Click on the following link for program details: GEN Contract Services Summit
The GEN Drug Discovery Theater will be held in Booth #4243 on Wednesday, June 29, from 10:00 am until 5:00 pm. Click on the following link for program details: GEN Drug Discovery Theater
And be sure to stop by the GEN Exhibition Booth (#4213) to share in the celebration of our 30th Anniversary. You can enter a contest to win an iPad, sign up for GEN e-newsletters and receive a free T shirt, and meet GEN editors and reporters.
Genetic Engineering & Biotechnology News (GEN, www.genengnews.com) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, such as news and analysis, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.